Publications
35
Citations
501
Est. group size
—
Recurring co-author estimate
Active years
20
Publishing since 2007
Nicole Skinner studies how the human immune system, particularly antibodies and B cells, responds to viral infections such as hepatitis C virus (HCV), hepatitis B virus (HBV), and SARS-CoV-2. Much of the work focuses on identifying 'broadly neutralizing antibodies' (antibodies capable of blocking many different strains of a virus) and understanding the immune features linked to natural clearance of infection, which has implications for vaccine design. The research also touches on immune cell dysfunction in chronic viral infections and autoimmune-like antibody responses seen in severe COVID-19.
Publication output has been modest but has grown somewhat since 2018, with a peak of four papers in both 2021 and 2023, averaging just over two publications per year over the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- mAbClust with AlphaFold 3 avoids hallucinations to define a quaternary broadly neutralizing HCV epitope
bioRxiv (Cold Spring Harbor Laboratory) · 2026
- High-dimensional droplet digital PCR of multiple hepatitis B splice variants in serum, liver, and tissue culture
Journal of Virological Methods · 2025
- Broadly Neutralizing Antibody Characteristics in Hepatitis C Virus Infection and Implications for Vaccine Design
Vaccines · 2025
- Convergent evolution and targeting of diverse E2 epitopes by human broadly neutralizing antibodies are associated with HCV clearance
Immunity · 2024
- Convergent antibody responses are associated with broad neutralization of hepatitis C virus
Frontiers in Immunology · 2023
- Corrigendum: Convergent antibody responses are associated with broad neutralization of hepatitis C virus
Frontiers in Immunology · 2023
- Contributors
Elsevier eBooks · 2023
- Hepatitis C Vaccines
Elsevier eBooks · 2023
- IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial function
JCI Insight · 2022
- B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection
PLoS Pathogens · 2022
- Durable SARS-CoV-2 B cell immunity after mild or severe disease
Journal of Clinical Investigation · 2021
- The Time is Now: A Call for Renewed Support of Infectious Diseases Physician-Scientist Trainees in the Era of Coronavirus Disease 2019
The Journal of Infectious Diseases · 2021
- Decreased Activated CD4 <sup>+</sup> T Cell Repertoire Diversity After Antiretroviral Therapy in HIV-1/HCV Coinfection Correlates with CD4 <sup>+</sup> T Cell Recovery
Viral Immunology · 2021
- Convergent antibody responses associated with broad neutralization of hepatitis C virus and clearance of infection
medRxiv · 2021
- Broadly neutralizing antibodies against hepatitis C virus: location, location, location
Journal of Hepatology · 2020
- Journal of Clinical Investigation×2
- Frontiers in Immunology×2
- medRxiv×2
- Elsevier eBooks×2
- Proceedings of the National Academy of Sciences×1
- Jonathan R. Honegger
Medicine · The Ohio State University
- Laura García
Medicine · Indiana University
- Steve Leumi
Medicine · The Ohio State University
- Haley Pritchard
Medicine · Indiana University
- Khalid Mumtaz
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile